{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:39:45Z","timestamp":1793036385444,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["055796"],"award-info":[{"award-number":["055796"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biologicals.2026.101901","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:08:17Z","timestamp":1786774097000},"page":"101901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Supporting 3Rs approaches in biologicals testing: responses from a survey of Manufacturers, Contract Research Organisations, National Control Laboratories and National Regulatory Authorities"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-2432","authenticated-orcid":false,"given":"Elliot","family":"Lilley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shajahan","family":"Shaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9864-3789","authenticated-orcid":false,"given":"Sarah","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Stickings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2026.101901_bib1","series-title":"3Rs in quality control of human vaccines: opportunities and barriers","first-page":"76","author":"Uhlrich","year":"2019"},{"key":"10.1016\/j.biologicals.2026.101901_bib2","article-title":"Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: summary of NC3Rs final report to WHO Expert Committee for Biological Standardisation","volume":"89","author":"Lilley","year":"2025","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib6","unstructured":"European Vaccine Initiative. https:\/\/www.euvaccine.eu\/post\/vac2vac-vaccine-batch-to-vaccine-batch-comparison-by-consistency-testing-successfully-completed (accessed 12 February 2026)."},{"key":"10.1016\/j.biologicals.2026.101901_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biologicals.2020.07.010","article-title":"Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities","volume":"68","author":"Akkermans","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib9","first-page":"30","article-title":"The vaccines consistency approach project: an EPAA initiative","volume":"2015","author":"De Mattia","year":"2015","journal-title":"Pharmeur Bio Sci Notes"},{"key":"10.1016\/j.biologicals.2026.101901_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.provac.2011.10.002","article-title":"Non-animal replacement methods for human vaccine potency testing: state of the science and future directions","volume":"5","author":"McFarland","year":"2011","journal-title":"Procedia in Vaccinology"},{"key":"10.1016\/j.biologicals.2026.101901_bib11","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/S0264-410X(02)00192-5","article-title":"Reduction of animal use in human vaccine quality control: opportunities and problems","volume":"20","author":"Metz","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2026.101901_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/14760584.2021.1977628","article-title":"Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines","volume":"20","author":"van den Biggelaar","year":"2021","journal-title":"Expert Rev Vaccine"},{"key":"10.1016\/j.biologicals.2026.101901_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2023.101721","article-title":"Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: responses from a survey of National Control Laboratories and National Regulatory Authorities","volume":"84","author":"Lilley","year":"2023","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2022.11.002","article-title":"Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: responses from a survey of vaccines and biological therapeutics manufacturers","volume":"81","author":"Lilley","year":"2023","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biologicals.2021.10.002","article-title":"Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals","volume":"74","author":"Lilley","year":"2021","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2020.05.003","article-title":"Removal of the innocuity test from The International Pharmacopoeia and WHO recommendations for vaccines and biological products","volume":"66","author":"Lei","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib17","series-title":"Expert Committee on Biological Standardization: seventy-eighth report","first-page":"21","year":"2024"},{"key":"10.1016\/j.biologicals.2026.101901_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2023.101702","article-title":"The future of pyrogenicity testing: phasing out the rabbit pyrogen test. A meeting report","volume":"84","author":"Cirefice","year":"2023","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101901_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2025.101862","article-title":"Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products","volume":"92","author":"Feavers","year":"2025","journal-title":"Biologicals"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:07:30Z","timestamp":1793034450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105626000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"alternative-id":["S1045105626000291"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101901","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supporting 3Rs approaches in biologicals testing: responses from a survey of Manufacturers, Contract Research Organisations, National Control Laboratories and National Regulatory Authorities","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}],"article-number":"101901"}}